Iobenguane Recruiting Phase 2 Trials for Neuroblastomas / Neoplasms / Neuroectodermal Tumors Treatment

IndicationsStatusPurposePhase
RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT03561259A Study of Therapeutic Iobenguane (131-I) for Relapsed, High-Risk Neuroblastoma Subjects